We are now about 485 Days to Event ,,,
LoL .. i thought it was a good buy at $5 .. i bought 110,000 shares today at avg of $2.75
I see STS ph3 worth $5 to $15 .. very conservative to very optimist .. I give it a 75% chance of success it
just assumptions ...
3,500 patients peak per year combined US and Europe ... $45,000 premium per year for aldox .. $150M per year
I also used 80 million shares which is 10 million more than all shares from option, warrants and 55m outstansding
ongoing ph3 has a 75% chance of success. This indication alone is valued at $600M .. With 80 million shares (with options and warrants) that is about $6 a share
the longer the better .. now we are 455 days ... some patients living very long since measuring .. good news for patients
assuming EXEL modifies its rights for the profit sharing in the US with a royalty stream on a global basis, what royalty can company expect per year?
this indication and what royalty can company expect per year?
there is no lock in 1.92 to 1.99 ... cagp bought about 12.5M shares for about $25M about 7 years ago and now willing to sell that at a loss for $1.5 .. big loss considering interest on $25M .. looks like they don't want to sell below $1.5, but that is not known yet
As for CREG, CEO purchase is big dilution at $1.37 ... one possibility is that CREG wanted to dilute to grow and CAGP didn't like it so, they decided to exit (this would be best scenario for shareholders buying at $1.37)
Another possibility is CREG found out company is scam and decided to exit .. given CAGP waited 6 years to come to this conclusion makes this also not a high probability
This is a confusing stock and my suggestion is not to buy unless this goes over $1.55 and stays there for a week
i am not sure understand you ..
i think the 9 million shares of CAGP can be quickly absorbed if CREG is not a scam and real investors think there is money to be made .. if you believe in the numbers, it should be trading at $4 now .. there is a reason it is off by 60%
less dilution .. only three explanations
1- CAGP did not want to sell at $1.37 .. unlikely as they seem willing to sell at $1.5
2- CREG needs the cash infusion .. again unlikely as a company with such great financials need so much dilution
3- CEO is a theif and company is total scam ... either CEO never paid the money to CREG and everyone is into this scam and that is why CAGP wants out .. this is a possibility ... if that would be the case, we should see CAPG dump millions below $1
So, I have to say that this is a total mystery ... where CEO buys 13M and a willing shareholder wants to sell 10M and company does not look like it needs cash .. or does it .. also where does CEO gets this amount of money with the little salary he gets
it does smell like a scam here
if it stays like this, it could absorb rest of CAGP shares which seem to be willing to sell at $1.50
it is interesting that we have good volume here . .am not sure why as CEo bought its shares a months ago
Guess buyers decided to buy in once bottom was placed in low $1
make your call
add also 14m for ceo share purchase and 8m for yida project .. you get about 83m
this company is cheap on any metric ... i do not think it will go much lower than ceo purchase price .. my estimate is low of 1.20
A threat, but not a large threat
83m shares and he owns 32m .. still off from 50% ... Best way he can get rich is stock price go up .. we will see if carlye sells below ceo purchase price ..
at 20 cents share for the rest of the shares.
... bought a little $2.49 ..